Explore the categories so you can find more about your search.

Categorie > Muscular Dystrophy

Mayor Boosts Disabled Sports Participation In London

Categorie : Muscular Dystrophy
Mayor of London Ken Livingstone published 'Inclusive and Active' - an action plan designed to help increase the number of disabled people in London participating in any sport at any level.Disabled Londoners have fewer opportunities or choice of sports activites and facilities than others, leadin ...

read more Mayor of London Ken Livingstone published 'Inclusive and Active' - an action plan designed to help increase the number of disabled people in London participating in any sport at any level.Disabled Londoners have fewer opportunities or choice of sports activites and facilities than others, leadin read more Sun Oct 2007 Sun Oct 2007

RNA Binding Proteins At Heart Of Problem In Myotonic Dystrophy Type 1

Categorie : Muscular Dystrophy
A new mouse model for myotonic dystrophy -- the most common form of adult-onset muscular dystrophy -- helped Baylor College of Medicine researchers show that levels of CUGBP1, a protein that binds and controls the activity of the genetic material RNA, increase early in affected c ...

read more A new mouse model for myotonic dystrophy -- the most common form of adult-onset muscular dystrophy -- helped Baylor College of Medicine researchers show that levels of CUGBP1, a protein that binds and controls the activity of the genetic material RNA, increase early in affected c read more Sun Oct 2007 Sun Oct 2007

Find A More Accessible Dealer At Motability.co.uk And Directenquiries.com

Categorie : Muscular Dystrophy
Disabled motorists can now pinpoint the most accessible dealers in their area, using a new search tool on the Motability websiteMotability, the leading car scheme for disabled people, has worked with directenquiries.com the Nationwide Access Register, to publish online access information about each ...

read more Disabled motorists can now pinpoint the most accessible dealers in their area, using a new search tool on the Motability websiteMotability, the leading car scheme for disabled people, has worked with directenquiries.com the Nationwide Access Register, to publish online access information about each read more Sun Oct 2007 Sun Oct 2007

MDA Telethon Raises Record 63.8 Million Dollars

Categorie : Muscular Dystrophy
Jerry Lewis made good on his annual promise to raise at least "one dollar more" for the fight against muscular dystrophy. The Muscular Dystrophy Association's 42nd Jerry Lewis Labor Day Telethon set a record of 63,759,478 dollars in contributions and pledges, which will fund research, services and i ...

read more Jerry Lewis made good on his annual promise to raise at least read more Sun Oct 2007 Sun Oct 2007

Wisconsin Man Receives Robert Ross MDA National Achievement Award

Categorie : Muscular Dystrophy
Michael Neufeldt of New Berlin, Wis., has been named the recipient of the Muscular Dystrophy Association's 2008 Robert Ross National Personal Achievement Award. The award will be announced during the national broadcast of the Jerry Lewis MDA Labor Day Telethon. Initiated in 1992, the national awards ...

read more Michael Neufeldt of New Berlin, Wis., has been named the recipient of the Muscular Dystrophy Association's 2008 Robert Ross National Personal Achievement Award. The award will be announced during the national broadcast of the Jerry Lewis MDA Labor Day Telethon. Initiated in 1992, the national awards read more Sun Oct 2007 Sun Oct 2007

Second Protein Discovered That Doubles The Muscle-Building Effect In Mice Lacking Myostatin

Categorie : Muscular Dystrophy
The Johns Hopkins scientist who first showed that the absence of the protein myostatin leads to oversized muscles in mice and men has now found a second protein, follistatin, whose overproduction in mice lacking myostatin doubles the muscle-building effect. [click link for full article] ...

read more The Johns Hopkins scientist who first showed that the absence of the protein myostatin leads to oversized muscles in mice and men has now found a second protein, follistatin, whose overproduction in mice lacking myostatin doubles the muscle-building effect. [click link for full article] read more Sun Oct 2007 Sun Oct 2007

Knopp Neurosciences Initiates Phase 1 Clinical Trial Of KNS-760704 In ALS Development Program

Categorie : Muscular Dystrophy
Knopp Neurosciences Inc. ("Knopp") announced the initiation of a Phase 1 clinical trial of KNS-760704, a small molecule therapy in development for the treatment of amyotrophic lateral sclerosis (ALS). This randomized, double-blind, placebo-controlled, single ascending dose study in h ...

read more Knopp Neurosciences Inc. ( read more Sun Oct 2007 Sun Oct 2007

Muscular Dystrophy - National Conference And Big Push Fun Day, UK

Categorie : Muscular Dystrophy
People were welcomed into the Church House Conference Centre with tea and coffee and were invited to take part in question and answer surgeries with MDC Care Advisors and view research posters produced by young scientists whose projects are funded by the charity. People then took part in workshops h ...

read more People were welcomed into the Church House Conference Centre with tea and coffee and were invited to take part in question and answer surgeries with MDC Care Advisors and view research posters produced by young scientists whose projects are funded by the charity. People then took part in workshops h read more Sun Oct 2007 Sun Oct 2007

Time Perception Research Has Implications For Free Will

Categorie : Muscular Dystrophy
Scientific experiments by a University of Queensland researcher have shown that our own brain activity can influence our sense of timing. Work by Dr Derek Arnold of the UQ School of Psychology goes against a widely held belief that activity in the cortex of the human brain does not influence how we ...

read more Scientific experiments by a University of Queensland researcher have shown that our own brain activity can influence our sense of timing. Work by Dr Derek Arnold of the UQ School of Psychology goes against a widely held belief that activity in the cortex of the human brain does not influence how we read more Sun Oct 2007 Sun Oct 2007

Lobby At The Scottish Parliament On 19 September - Muscular Dystrophy Campaign

Categorie : Muscular Dystrophy
Minister for Public Health, Shona Robison MSP, will be joined by families and individuals living with muscle disease on Wednesday 19 September to lobby Parliament and the Government to improve services for those living with the condition.The 'My Life' campaign calls on the Scottish Government to mak ...

read more Minister for Public Health, Shona Robison MSP, will be joined by families and individuals living with muscle disease on Wednesday 19 September to lobby Parliament and the Government to improve services for those living with the condition.The 'My Life' campaign calls on the Scottish Government to mak read more Sun Oct 2007 Sun Oct 2007

Insights Into The Noxious Cause Of Lou Gehrig's Disease

Categorie : Muscular Dystrophy
There is no known cure for amyotrophic lateral sclerosis (ALS), often known as Lou Gehrig disease and motor neuron disease. ALS is a progressive, fatal, neurodegenerative disease caused by the degeneration of nerves that control voluntary muscle movement. [click link for full article] ...

read more There is no known cure for amyotrophic lateral sclerosis (ALS), often known as Lou Gehrig disease and motor neuron disease. ALS is a progressive, fatal, neurodegenerative disease caused by the degeneration of nerves that control voluntary muscle movement. [click link for full article] read more Sun Oct 2007 Sun Oct 2007

Gene Deletions Improve Survival In Mice With ALS

Categorie : Muscular Dystrophy
University of Iowa researchers investigating the basic biology of cell signaling have made a discovery that may have therapeutic implications for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases.The UI team, led by John Engelhardt, Ph.D., professor and head of anatomy and cel ...

read more University of Iowa researchers investigating the basic biology of cell signaling have made a discovery that may have therapeutic implications for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases.The UI team, led by John Engelhardt, Ph.D., professor and head of anatomy and cel read more Sun Oct 2007 Sun Oct 2007

Pharmacokinetic And Safety Results From Phase 2 Study Of PTC124 In Duchenne Muscular Dystrophy

Categorie : Muscular Dystrophy
PTC Therapeutics, Inc. (PTC), a biopharmaceutical company focused on the discovery, development and commercialization of small-molecule drugs targeting post-transcriptional control mechanisms, today announced pharmacokinetic and safety data from a Phase 2 clinical trial of PTC124 in patients ...

read more PTC Therapeutics, Inc. (PTC), a biopharmaceutical company focused on the discovery, development and commercialization of small-molecule drugs targeting post-transcriptional control mechanisms, today announced pharmacokinetic and safety data from a Phase 2 clinical trial of PTC124 in patients read more Sun Oct 2007 Sun Oct 2007

PTC Therapeutics Announces Pharmacokinetic And Safety Results From Phase 2 Study Of PTC124 In Duchenne Muscular Dystrophy

Categorie : Muscular Dystrophy
PTC Therapeutics, Inc. (PTC), a biopharmaceutical company focused on the discovery, development and commercialization of small-molecule drugs targeting post-transcriptional control mechanisms, announced pharmacokinetic and safety data from a Phase 2 clinical trial of PTC124 in patients with ...

read more PTC Therapeutics, Inc. (PTC), a biopharmaceutical company focused on the discovery, development and commercialization of small-molecule drugs targeting post-transcriptional control mechanisms, announced pharmacokinetic and safety data from a Phase 2 clinical trial of PTC124 in patients with read more Sun Oct 2007 Sun Oct 2007

Jerry Lewis Urges Congress To Protect Medicare Benefits Of People With Neuromuscular Diseases

Categorie : Muscular Dystrophy
Legendary entertainer and MDA National Chairman Jerry Lewis has sent letters to Congress urging passage of legislation protecting the Medicare benefits of those who rely on complex medical equipment and technology, including tens of thousands with progressive neuromuscular diseases. H.R. [click link ...

read more Legendary entertainer and MDA National Chairman Jerry Lewis has sent letters to Congress urging passage of legislation protecting the Medicare benefits of those who rely on complex medical equipment and technology, including tens of thousands with progressive neuromuscular diseases. H.R. [click link read more Sun Oct 2007 Sun Oct 2007

Smoking Rates Highest Among People With Disabilities

Categorie : Muscular Dystrophy
Smoking prevalence among people with disabilities is nearly 50 percent higher than among people without disabilities (29.9 percent vs. 19.8 percent), according to a new study from the Centers for Disease Control and Prevention (CDC) in Preventing Chronic Disease. The study found that in 2004, smokin ...

read more Smoking prevalence among people with disabilities is nearly 50 percent higher than among people without disabilities (29.9 percent vs. 19.8 percent), according to a new study from the Centers for Disease Control and Prevention (CDC) in Preventing Chronic Disease. The study found that in 2004, smokin read more Sun Oct 2007 Sun Oct 2007

ALS TDI Completes Gene Expression Profile Of Lou Gehrig's Disease In Mice

Categorie : Muscular Dystrophy
The ALS Therapy Development Institute (ALS TDI) announced that it has completed the first phase of a comprehensive gene expression database for ALS with the profiling of the SOD1 mouse model of amyotrophic lateral sclerosis -- ALS, or Lou Gehrig's disease. The second phase, profiling of hu ...

read more The ALS Therapy Development Institute (ALS TDI) announced that it has completed the first phase of a comprehensive gene expression database for ALS with the profiling of the SOD1 mouse model of amyotrophic lateral sclerosis -- ALS, or Lou Gehrig's disease. The second phase, profiling of hu read more Sun Oct 2007 Sun Oct 2007

Scottish Conference - Muscular Dystrophy Campaign

Categorie : Muscular Dystrophy
The Muscular Dystrophy Campaign's Scottish conference took place on Saturday 22 September. The presence of several staff from the London Office helped to remind everyone that the Scottish membership is distinctive but very much part of the main organisation. [click link for full article] ...

read more The Muscular Dystrophy Campaign's Scottish conference took place on Saturday 22 September. The presence of several staff from the London Office helped to remind everyone that the Scottish membership is distinctive but very much part of the main organisation. [click link for full article] read more Sun Oct 2007 Sun Oct 2007

MDC-Led Consortium Leads To World-first Clinical Trial, UK

Categorie : Muscular Dystrophy
A gene therapy clinical trial begins this week which could offer new hope to boys and young men with muscular dystrophy. A new treatment, called molecular patch therapy, has been developed which has the potential to give boys born with Duchenne muscular dystrophy (DMD) the chance to preserve their m ...

read more A gene therapy clinical trial begins this week which could offer new hope to boys and young men with muscular dystrophy. A new treatment, called molecular patch therapy, has been developed which has the potential to give boys born with Duchenne muscular dystrophy (DMD) the chance to preserve their m read more Sun Oct 2007 Sun Oct 2007

PTC Therapeutics Announces Additional Results From Phase 2 Study Of PTC 124 In Duchenne Muscular Dystrophy

Categorie : Muscular Dystrophy
PTC Therapeutics, Inc. (PTC), a biopharmaceutical company focused on the discovery, development, and commercialization of small-molecule drugs targeting post-transcriptional control mechanisms, today announced additional data from a Phase 2 clinical trial of PTC124 in patients with Duchenne ...

read more PTC Therapeutics, Inc. (PTC), a biopharmaceutical company focused on the discovery, development, and commercialization of small-molecule drugs targeting post-transcriptional control mechanisms, today announced additional data from a Phase 2 clinical trial of PTC124 in patients with Duchenne read more Sun Oct 2007 Sun Oct 2007

1 | 2 | 3 | 4 next >>>



     


Custom Search